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As many health phenomena seem to be affected directly and indirectly by the 
microbiome, gut microbiome research has increased in the last decade. Issues such as allergies, 
cancer, obesity, and other health complications have been shown to be influenced by the 
microbiome. Most of gut microbiome research is done by collecting and sequencing the DNA of 
the microbiome of the fecal matter from model organisms or human subjects. Studies that use 
this method of sample collection and analysis assume that fecal matter microbiomes are similar 
to intestinal microbiomes, and that it can be used as a proxy. At present, no published studies 
exist which directly compare stool microbial composition and intestinal microbial composition. 
Bacterial composition was found to be different at all levels of taxonomy between stool and the 
different portions of the intestines tested. Uni-variate analysis shows significance between the 
two main phyla Firmicutes and Bacteroidetes, as well as main genera like Odoribacter, 
Porphyromonas and Alistipes. Relevant species Desulfovibrio desulfuricans and Odoribacter 
splanchicus were also found to be significantly different in relative abundance between stool and 
some parts of the intestines. Alpha-diversity was not significantly different between all parts of 




with stool having slightly higher diversity. Looking at the bacterial composition of both 
environments and the relative abundances of the dominant taxa, one can see that that there are 
key differences between the intestines and stool. The microbial composition at all levels of 
taxonomy was found to be different, therefore, research that targets the gut microbiome should 
look closely at the specific taxa being observed. Phyla like Firmicutes and Bacteroidetes were 
found to have different abundance within the portions of the intestine and stool, suggesting that 
phyla level analysis should be performed by observing each community separately.  
Interestingly, diversity analysis was not found to be significant, suggesting the composition is 
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 The gut microbiome is currently a very popular field of study. Fifteen years ago, a 
keyword search using the term “microbiome” on a journal’s search would have resulted in a very 
limited number of papers. A more recent Google Scholar search using the term “microbiome 
yielded over 200,000 papers. If the term “gut” is added to the search, 31,100 articles are found. 
Microbiome scientists have found a field of research that may have an influence in all aspects of 
biology and human health. Recent studies have shown connections between the composition of 
the gut microbiome and: the immune system, mental health and brain chemistry, and obesity (1). 
So far, gut microbiome researchers have only scratched the surface of some of these phenomena, 
allowing for further research to assess the biological implications of the connections made, 
adequacy of methodology and medical significance.  
 
Gut Microbial Composition  
 The intestinal microbiome is a highly diverse system that is mostly composed of 
commensal organisms. Biodiversity is defined as: “the variety and variability of biological 
organisms”, Therefore, by these parameters, the microbiome is a highly diverse environment. 
The gut microbial content varies between portions of the intestinal tract, but generally is made of 
~103 - 1014 microbes per gram of content. The cumulative genomic material of the gut 
microbiome contains 100 times more genes than our own genome (1). Human gut microflora is 
dominated by member of two main phyla, the Firmicutes and Bacteroidetes, which form roughly 




Bifidobacterium, Lactobacillus and Ruminococcus (2). Although the microbiome composition 
varies during early development, in humans, it stabilizes around the age of three (3, 4). 
 
Human Gut Microbial Composition 
 The area termed “the gut” for humans is shown in Figure 1. The stomach is inhabited 
predominantly by organisms belonging to the genera Lactobacillus and Streptococcus. Bacterial 
biodiversity is very low in this portion of the intestinal tract due to the highly acidic environment 
of pH 1-2. Bacterial biodiversity in the duodenum and jejunum is higher due to the less acidic 
environment of 5.7-6.4 pH. Organisms belonging to the genera Lactobacillus, Escherichia and 
Enterococcus dominate this section of the intestinal tract. The ileum is a highly diverse 
environment with many organisms belonging to the genera Enterobacter, Enterococcus, 
Bacteroidetes, Clostridium and Lactobacillus. The ileum is a neutral environment with a pH 
range of 7.3-7.7. In humans, the cecum and colon have similar community structure and 
diversity. The cecum is the portion of the gut that connects the small intestine and the large 
intestine. The colon is the portion closest to the rectum in the large intestine. These two sections 
have neutral environments, and the highest number of species in the intestinal tract. Organisms 
belonging to the genera: Bacteroidetes, Eubacterium, Bifidobacterium, Ruminococcus, 






Figure 1. Human Gastro-intestinal Tract microbial composition (4). 
Mouse Gut Microbial Composition 
Mice are the animal model most commonly used to study gut microbial composition and 
the effects that changes in diet and exercise have on the gut microbiome. The gastro-intestinal 
anatomy of the mouse is a similarly complex version of the human intestinal tract, with very 
comparable structures (Figure 2). The human and mouse stomach are very similar to each other 
and the human gut microbiome and the mouse gut microbiome are both dominated by the same 
phyla, Firmicutes and Bacteroidetes. When looking deeper into the species taxonomic level, one 
can observe differences between the human and mouse microbiomes. According to Ley and 
colleagues 85% of microorganisms found in the mouse gut microbiome are not found in the 
human gut microbiome (6). Another study took the task of assessing these finding by using 
metagenomics techniques in already existing datasets of human fecal matter and mice cecal 
samples. The researchers recognized that having only fecal matter data for humans (as opposed 




researchers in the field. The mouse microbiome and the human microbiome share a large number 
of microorganisms with roughly 79 genera shared by both organisms (7).  
 
Figure 2. Mouse intestinal tract vs. human intestinal tract (7). 
 
 Mouse intestinal microbial communities are composed of species belonging to the genera 
Lactobacillus, Alistipes, Roseburia, Bifidobacterium, Clostridium, and others. This composition 
is very similar to that of humans, but the content, as in abundance, seems to be different. The 
relative abundances of these genera differ greatly between mouse and human, but, interestingly, 
the species richness is similar (Figure 3). Although some differences are observed in abundances 
of certain taxa, the mouse microbiome is still considered a good model to study microbial 
communities and the effects of changes to the environment (8). Germ-free mice, for example, are 
a great way to study the effect of certain microbial communities in the environment. These mice 




This allows the researcher to create a gut microbiome specific to individual mice under study. 
Phenomena like obesity, dieting and probiotics have been studied using germ-free mice (8). 
 
Figure 3. Relative abundances of certain intestinal genera are different between humans and mice, but 
species richness is very similar (8). 
 




 Recent gut microbiome research uses fecal matter as a source of the gut microbiome, 
rather than samples taken directly from the intestine, primarily due to the relative ease of 
collection. In a Google Scholar search for “gut microbiome”, the first twenty-two references that 
appeared used feces rather than intestinal samples (Table 1). Interestingly, research that 
specifically compares the composition of fecal microbiota to that obtained from intestinal 








Table 1  Comparison between usage of stool samples as a proxy for gut microbial composition, usage of 
intestinal samples, and the usage of both sample types. 
 
Used feces as a proxy for 
intestine microbial 
composition 
Used intestinal samples Used both fecal and 
intestinal samples 
Turnbaugh et al.., 2009 Lagkouvardos et al.., 2016 Eckburg et al.., 2005 
Kalliomaki et al.., 2008 Markle, et al.., 2013 Kleessen et al.., 2001 
Mai et al.., 2011 Turbaugh et al.., 2006  
Gill et al.., 2006 Ravussin et al.., 2012  
Ley et al.., 2006   
Qin et al.., 2010   
De Fillipo et al.., 2010   
Ley et al.., 2005   
Jumpertz et al.., 2011   
Routy et al., 2018   
Gopulakrishnan et al., 2018   
Halfuorson et al., 2017   
Xia et al., 2017   
Wu et al., 2017   
InSerra et al., 2019   




Nucleic-acid Based Techniques  
 
 The gut microbiome is a very challenging system to research and observe. Early 
techniques used to identify species were culture based and employed biochemical testing. These 
types of testing are beneficial to observe microorganism in pure cultures, but have proved 
limiting for capturing the extent of species richness. Because more than 80% of our gut 
microbiome is of anaerobic nature and fastidious in growth requirements, only about 1% of the 
microbes in our gut have been cultivated in the laboratory setting with traditional culture-based 
methods (9). Microbiome research that targets identification, characterization, and multiple 




assess counts and abundance of each species. Nucleic acid-based techniques have been very 
useful to identify organisms to the species and sub-species level, and have provided a new 
avenue of research with the different possible questions they can answer. Some of these 
techniques use bacterial ribosomal RNA and/or DNA, and others use the collective DNA 
extracted from a particular environment (10) (Figure 4).  
 
Figure 4. Diagram of microbiome characterization techniques (42). 
 
    16S rRNA amplicon sequencing 
One technique that has been widely used in the field of gut microbiome research is 16S 
rRNA amplicon sequencing. This technique uses rRNA sequences to provide a taxonomic profile 
for microorganisms present in the environment. It is called rDNA amplicon sequencing because 
it uses ribosomal RNA genes as a basis for taxonomic assignment. The ribosome is a structure 
that serves as a protein generator (Figure 5). It uses amino acids and mRNA to yield a 
polypeptide chain that eventually gets folded into a protein. The ribosome consists of several 




Svedberg coefficient, is a non-SI unit that serves as a measure of how big and at what rate a 
particle moves in an environment subjected to high G-force, such as those incurred in a 
centrifuge. This unit is based on time, but it is not translated as seconds or minutes, but as a rate 
of how fast can a molecule move, which correlates to how big it might be as well, therefore the 
values assigned to each sub-unit are not additive, but only descriptive (11).  
 
Figure 5. 3D structure of a bacterial ribosome. Green=small sub-unit, Blue=large sub-unit (43). 
 
Prokaryotes (Bacteria and Archaea) have free-floating 70S ribosomes in their cytoplasm. 
This ribosome is divided into a 30S (small) and a 50S (large) sub-unit, which are each divided 
each into more sub-units. The 50S sub-unit is divided in two RNA molecules named 23S and 5S. 
The 30S product contains the sub-unit that is most commonly used in prokaryotic taxonomy, the 
16S subunit. Since it is the most conserved sequence and the easiest to track with PCR 
(Polymerase Chain Reaction), the 16S rRNA gene is the preferred sequence for multiple 
molecular-based techniques used to identify microorganisms in an environment. Figure 6 shows 




sequence that is conserved, and multiple variable regions which can be used to differentiate 
between phyla, genera and species. Some conserved regions are unique to prokaryotes and can 
therefore be used as sites for primers to bind to amplify prokaryotic DNA. PCR amplification of 
the variable regions tells the researcher the necessary information to assign taxonomic 
designations by cross-referencing sample data with a public database that contains many known 
sequences of bacterial 16S rDNA to pin-point the exact taxonomic designation for all the 
sequences in the amplified sample (10). 16S rRNA amplicon sequencing has proven better, than 
other nucleic-acid based techniques, for testing large samples, but it also has lower resolution 
than other techniques. Other advantages of this technique are: it is able to exclude all non-
bacterial organisms, ease of access, it can yield accurate taxonomic designations and is less labor 
intensive (12).   
  
 
Figure 6. 16S rRNA amplicon production process (42). 
    
 
  Metagenomics 
 A more sensitive technique that is also highly used in microbiome research is 




extracting and sequencing all the DNA in a sample. This allows the researcher to find important 
genes (virulence or certain metabolic genes, for example) and observe whether they are present 
in the environment or not, providing information about metabolic pathways that can be 
performed by that certain organism (14). Metagenomics not only allows for assignment of 
taxonomic designations, but also reveals the whole gene repertoire of the system (13). 
Techniques like “shotgun sequencing” and metagenome analysis can provide higher resolution, 
allowing the researcher to assign designations as specific as sub-species and strain. These 
techniques have proven useful for creating a genetic profile of the microbial environment, often 
identifying specific genes that produce virulence factors or important enzymes more often than 
other molecular-based technologies (13). 
    Metatranscriptomics 
 Metatranscriptomics is a group of techniques that study the transcriptome of a microbial 
community. The transcriptome is the collective sum of messenger RNA and other RNA 
products’ sequence information. The focus of these techniques is the isolation and sequencing of 
RNA fragments to assess expression levels to infer metabolic activity and population viability. 
(15; 16; 17). This technique can be challenging in environments that include both prokaryotic 
and eukaryotic RNA. Prokaryote RNA does not have a poly-A tail, therefore selection during 
cDNA synthesis is not possible as it is with eukaryotes. Probes targeting certain sequences of 
RNA that are bound to magnetic beads to exclude the unwanted eukaryotic and ribosomal RNA 
is a highly used method. RNA is then reverse-transcribed to cDNA and sequenced to determine 





    Metabolomics 
Metabolomics is the branch of genomics that studies the metabolome. The metabolome is 
the metabolic profile of microbial community in a particular an environment- it measures 
metabolites such as sugars, proteins, and lipids. Metabolomics is currently used to identify 
markers that could lead us to the development of diagnostic techniques for multiple diseases, 
observe biochemical stresses, identify microbial metabolic products, and characterization of 
disease-related metabolites (19; 20; 21; 22). Techniques like liquid and gas chromatography (LC, 
GC), mass spectrometry (MS) and nuclear magnetic resonance (NMR) allow for the researcher 
to develop a chemical profile of the system that can show what type of biochemical pathways are 
occurring in the environment. These techniques are better employed in research geared towards 
understanding the effect of metabolites on health and disease (23; 24; 25). Bacteria are 
responsible for the breakdown and production of some of these metabolites that can be studied 
through metabolomics. Metabolites like short-chain fatty acids (SCFAs), vitamins, other acids, 
bile salts, amino acids and other biomolecules can be produced or transformed by bacteria 
(Figure 7). Metabolomics can be used to create a metabolic profile that includes which 







Figure 7. Gut microbial metabolites and signaling molecules (23). 
 
Analysis of 16S rDNA data 
 Microbial community comparison bioinformatics uses 16S rDNA raw data to assign 
taxonomic designations and to calculate the genomic relatedness of two or more communities. 
The data is often extensive and complex. When studying the gut microbiome, each 16S RNA 
gene amplicon is referred to as an operational taxonomic unit (OTU). Each OTU represents a 
species of prokaryote. A single gut sample may have over 1000 species, where each species is 
represented by a population ranging from 10 to several million members. It would take a great 
amount of time to sort, group, analyze and plot these data. Therefore, multiple software 
platforms have been developed to accelerate the process and to create informative figures that 
accurately represent the composition of the microbiome. Software like mcaGUI, PICRUSt and 




microbiome research. Other programs like Qiime and Mothur are also effective, but are Python-
based and require a higher skill level in coding and bioinformatics.  All of these programs are 
ultimately used for 4 general categories of tasks. These categories are: (i) taxonomic assignation 
of individual OTUs, (ii) functional profiling, or assigning genes to metabolic pathways that can 
show the researcher the overall functional profile of the microbiome, (iii) community 
comparison, which identifies differences and similarities between the OTU make-up of two or 
more microbial communities, and (iv) meta-analysis, or the use of previously collected data to 





 This open-source program uses the R language and environments to provide multiple 
statistical tools and packages that can be used for microbial community comparison. It allows the 
researcher to create OTU tables with the abundances and counts of organisms obtained from the 
16S rDNA raw data. Other analysis can then be performed. Principal component analysis (PCA), 
richness and diversity estimates, and multiple-community comparisons are the most popular 
analyses performed (27).  
UniFrac 
 UniFrac is a community comparison measurement that takes into account the genetic 
relatedness of multiple communities. To assess the genetic distance between two communities it 
uses phylogenetic trees that are individually formed for each sample (28). A phylogenetic tree is 




branches and nodes, which represent genetic distance and taxa or common ancestors 
respectively. Branches that are closer together correspond to closely related 
microorganisms/communities. Branches that are further apart correspond to less related 
organisms and communities (29). UniFrac uses this model and by quantifying the phylogenetic 
distance between different sets of taxa in terms of length of the branch, it can provide a 
coefficient from 0-1 that corresponds to the level of relatedness between two or more 
communities. Microbial communities can also be clustered in a plot, visually showing 
similarities or differences between them (28). By using this measure one can observe that if 
relative abundances of each OTU are not taken into account, then all organisms have the same 
weight, yielding a UniFrac value that is only based on OTU richness. To reduce the impact that 
presence has over abundance, a weighted UniFrac can be used. This measure allows the 
researcher to observe similarities of communities by relative abundances and not just by 
presence, diminishing the effect of low abundant present organisms. The un-weighted version 
just looks at the presence of organisms giving equal statistical power to all OTUs even if they are 
in low abundance in the environment (28;30).  
 
MicrobiomeAnalyst 
MicrobiomeAnalyst is a recently-developed web-based software that contains four 
modules of work, which are the following: Maker Data Profiling, Shotgun Data Profilin, 
Projection with Public Data and Taxon Set Enrichment Analysis. Maker Data Profiling is a 
module that takes 16S rRNA sequence data and uses it to calculate measures like α−diversity 
and β−diversity using a variety of statistical methods (Shannon, Chao-1, ACE, etc) (26).  These 




an environment, and having high biodiversity is a marker of community health. α−diversity is 
the richness and evenness of the organisms within a single community and β−diversity is the 
richness and evenness between communities. Shannon’s index is a measurement of how diverse 
a community is, while taking into account the total amount of organisms and total amount of 
each organism. This index yields a value from 0-1. The closer to 1 it gets the more diverse the 
environment is. SDP is a module meant to analyze and organize metagenomics and meta-
transcriptomics data. PPD allows for the researcher to compare the data obtained with already 
published and analyzed data. Finally, TSEA is a module designed to assess the biological 
implications or effects of a certain list of OTUs in the environment. For the purpose of this 
project, MDP will be used, since it is the most appropriate module for the questions asked (26). 
Figure 8 represents a flowchart that shows all possible analytic capabilities of 
MicrobiomeAnalyst, depending on format input.  
  
Figure 8. Microbiome Analyst flowchart representing all types of analysis depending on file input and 







Gut Microbiome in Health and Disease 
 
Multiple health related connections have been made between the gut microbiome and 
various diseases and conditions. Microbiome researchers have connected diseases and disorders 
like obesity, atopic diseases, allergies, stress, and others with the microbial composition of the 
gut (31). Most of these studies have one aspect in common:  the source of the samples used to 
assess the composition of the gut. Evidence supporting connections between conditions and 
diseases is based on the premise that stool microbial composition is a proxy for intestinal 
microbial composition; therefore, only fecal matter is used for microbiome samples. Even though 
no studies have demonstrated that fecal microbiomes are representative of the gut microbiome, 
many studies have relied on fecal microbiome biome data for their experiments. Table 2 
summarizes the relevant findings from select studies that have used mouse and human data from 
both fecal and cecal microbiomes. 
 
Knowledge gleaned from analysis of fecal samples 
 
In an experiment aimed to investigate if gut microbial composition can precede obesity, 
the researchers found that the presence of the genus Bifidobacterium was significantly decreased 
in overweight children. Bifidobacterium species are responsible for controlling the populations of 
other microbes during infancy. This suggested to the researchers that there is a link between 




connected to obesity. Obese individuals show an increase in the phylum Firmicutes compared to 
Bacteroidetes, and lean individuals have a balanced proportion (33).  
 Germ-Free (GF) mice are a great model for assessment of the implications of certain 
shifts in microbiome (dysbiosis) or the consequences of growth in a completely sterile 
environment for gut microbial composition and organismal health. Some immunological diseases 
and allergies have been correlated to microbial composition irregularities, or mal-developed 
microbiome (34). Germ-Free mice show mal-developed gut associated lymphoid tissue, lower 
counts of multiple leukocytes, poorly developed germinal centers, and low immunoglobulin 
levels, suggesting that not having a microbiome causes an overall detriment to the development 
of the immune system. (34). Certain microorganisms have been observed to aid in some of these 
processes and in immunomodulation as well. Organisms like Lactobacilli and Escherichia have 
been observed to induce T cell differentiation to a T helper lymphocyte 2 or T regulatory 
responses. This led researchers to conclude that these organisms promote a tolerogenic 
environment in the gastrointestinal tract (35). This, in turn, led microbiome researchers to 
connect allergies and atopic diseases to gut microbial composition and microbiome development. 
 Disorders and conditions like stress, anxiety and depression, Autism Spectrum Disorder, 
Parkinson ’s disease (Pd) and others have also been connected to dysbiosis and abnormalities in 
the gut microbiome (36). In an experiment aimed at understanding the relationship between the 
microbiome and stress, anxiety and depression, researchers found that GF mice have higher 
corticosterone when challenged with restraint to promote stress, than Specific Pathogen Free 
(SPF) mice. GF mice also exhibited reduced neurotrophic factor expression, which is a sign of 
potential neuronal mal-development. All of these issues were reversed by reconstitution of 




also share connections with the gut microbiome. For example, Pd was found to have a microbial 
aspect to the underlying cause of the disease. Sampson and colleagues (38) investigated the 
relationship between the gut microbiome and Pd’s pathophysiology. They found that GF mice 
colonized with Pd microbiota display Pd symptoms and behavior as well as reduces microglia 
activation. Microglia size and branching was reduced in Pd mice. The same was observed when 
GF mice were given Pd microbiota. Mice that had Pd symptoms and Human Pd patient samples 
had a higher UniFrac value than to the other sample groups. This indicates that Pd mice have 
very similar microbiomes to human Pd patients, alluding to a microbial profile that can be 




Cecal Sample Collection 
 
Another common sample collection method in the study of the effects of the gut 
microbiome on human health using mice as a model organism is to take tissue sections from the 
cecum. A few studies have used samples gained from tissue excision from the cecum or other 
portions of the gut and extract DNA from that to assess the microbial composition of the 
intestines (39;40;41). The research performed using this method of sample collection is scarce 
and uses mouse models. From all the research done for this project only 3 relevant articles were 
found to use only cecum sample collection (39;40;41).  
 An experiment focused on understanding the microbial composition of obese mice and 
comparing it to control mice found that diet induced obese mice had higher bacterial diversity 




diversity increased greatly. The phylum Firmicutes was observed to decrease in this weight 
reduction process, suggesting that the levels of these organisms are related to the obese 
phenotype. The phylum Bacteroidetes was observed to decrease in obese mice and to 
significantly increase during the weight reduction process, which suggests that there is a relation 
between this phylum and the lean phenotype. All of this evidence showed the researchers that the 
ratio of these two phyla might be correlated to the degree of obesity (39).  
 Results from another experiment changed the focus of study from obese phenotype to 
energy harvest and determined how well the microbiome from an obese animal is able to harvest 
nutrients and break down foods (40). The researchers found that samples from obese mice where 
observed to have higher amounts of sequences that code for enzymes responsible for breaking 
down indigestible elements. Also, GF mice gavaged with the microbiota of obese mice showed a 
significant increase in fat percentage compared to that of mice gavaged with lean microbiota or 
control microbiota (40). This evidence suggests that there is a strong bi-directional relationship 
between metabolic processes of the body and the gut microbiome. This has been observed with 
other systems as well, for example the immune system and the central nervous system (41;38). 
 Atopic diseases and autoimmune diseases like diabetes have also been correlated to gut 
microbial composition. In an experiment geared towards understanding sex-biased microbial 
composition and the potential of a hormonal induced microbial composition profile found that 
female mice have a different microbiome than male mice (41). It also suggested, that this can be 
a reason as to why women are more prone to diabetes. Using non-obese diabetic mice, the 
researchers assessed the relatedness and the implications of having male and female 
microbiomes in terms of glucose tolerance and insulin production. They concluded that females 




diabetes. This suggests that there is a sex-biased microbial composition that may confer 
protection or prevention to diabetes. This is still being researched, therefore there are no known 
mechanisms that underlie this process, but it is hypothesized that testosterone levels might be a 
factor (41).  
 
Table 2. Relevant finding from select studies that have used fecal and cecal data. 
  




Feces Obesity ↓ Bifidobacterium sp. 32 
Feces Obesity ↑ Firmicutes:Bacteriodetes 33 





Immunomodulation Lactobacillus, Escherichia 
coli promote a Th2 or Treg 
differentiation.  
34,35 
Feces α-Synucelopathies Bacterial gavage of human 
fecal microbiome into 
germ free mice causes 
Parkinson’s 
pathophysiology in mice 
38 
Cecum Obesity Bacteroidetes was less 
abundant in obese mice 
39 
Cecum Obesity Microbial gavage of lean 
mice into obese mice 
reduces fat percentage of 
obese mice  
40 
Cecum Diabetes Non-obese diabetic mice 
show a sex bias towards 
diabetes incident, which 
changes as microbial 
gavage is exchanged 
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Background: As many health phenomena seem to be affected directly and indirectly by the 
microbiome, gut microbiome research has increased dramatically in the last decade. Issues like 
allergies, cancer, obesity, and other health phenomena have been found to be influenced by the 
microbiome. Most of gut microbiome research is done by collecting and sequencing the DNA of 
the microbiome of the fecal matter from model organisms or human subjects. Studies that use 
this method of sample collection and analysis assume that fecal matter microbiomes are identical 
to intestinal microbiomes. At present, no published studies exist which directly compare stool 
and intestinal microbial composition. 
Results: Bacterial composition was found to be different at all levels of taxonomy between stool 
and the regions of the intestines tested. Univariate analysis shows significance between the two 
main phyla Firmicutes and Bacteroidetes, as well as main genera like Odoribacter, 
Porphyromonas and Alistipes. Relevant species Desulfovibrio desulfuricans and Odoribacter 
splanchicus were also found to be significantly different in relative abundance between stool and 




intestine and stool. β-diversity was found significant between the ileum and stool, with stool 
having slightly higher diversity.  
 
Conclusions: Looking at the bacterial composition of both environments and the relative 
abundances of the dominant taxa, one can see that that there are key differences between the 
intestines and stool. The microbial composition at all levels of taxonomy was found to be 
different, therefore, research that targets the gut microbiome should look closely at the specific 
taxa being observed. Phyla like Firmicutes and Bacteroidetes were found to have different 
abundance within the portions of the intestine and stool, suggesting that phyla level analysis 
should be performed by observing each community separately. Interestingly, diversity analysis 
was not found significant, suggesting the abundance is different, but the number of different taxa 
is similar across the intestinal tract and stool.  
 






 Microbiome research, specifically projects assessing the composition of the gut 
microbiome, have become a popular avenue of exploration. From the year 2000 to 2014 a pear 
reviewed article internet search for “Gut Microbiome” yielded ~40,000 articles, and when the 
word “Ecology” is added to the search it yielded ~13,500 papers. This is a huge increase from 
what was observed in the 90’s, where it was reported by Sekirov and colleagues that from 1990 
to 1995 no more than 500 articles were published on the gut microbiome (1). It would seem that 
microbiome researchers have successfully found a system that affects all other systems of the 
body. For example, research suggested that obesity could be explained by the composition of the 
gut microbiome, as well as a potential mechanism as to why allergies occur and why they are on 
the rise. Connections were also found between the immune system and the gut microbiome, and 
many more phenomena were connected to the gut microbiome (2;3;4). Microbial composition 
has become an important phenomenon to look at. With the help of the murine (mouse) 
microbiome, interesting research was performed showing, for example, the effects of diet and 
stress on the microbiome, microbial composition along the intestinal tract, what occurs when the 
microbiome is removed at an early age, among others (2;3;4). 
Mouse are a commonly used animal model used to study gut microbial composition and 
the effects of changes like diet and exercise have on the gut microbiome. The gastro-intestinal 
anatomy of the mouse is a similarly complex version of the human intestinal tract, with 
structures that are alike, although the composition is slightly different. Cross-sections of organs 
show some differences, but the same structures are present in both organisms and they perform 
similar functions (7). The human gut microbiome and the mouse gut microbiome are both 




species taxonomic level, one can observe differences between the two microbiomes. According 
to Ley and colleges 85% of species found in the mouse gut microbiome are not found in the 
human microbiome, (5). Even though this dissimilarity is observed there are still roughly 79 
genera shared by both humans and mice (6). Both of these findings suggest that composition is 
not necessarily dissimilar, but the lower one gets in taxonomy the more diversification these two 
organisms have.   
Mouse intestinal microbial communities are composed of species belonging to the genera 
Lactobacillus, Alistipes, Roseburia, Bifidobacterium, Clostridium, and others. This composition 
is similar to that of humans. Relative abundances, on the other hand, are different, as well as 
certain communities that are not in humans are found in mice (6; 7). Although, some researchers 
have alluded to the issue that these discrepancies and dissimilarities, between human and mouse, 
could be better studied if they did not lack comprehensive microbial data due to the inability to 
perform research in intestinal matter and fecal matter rather than just fecal matter (8). Even 
though mice and humans have dissimilarities, the mouse is still a good model to study 
interactions between microbes and the system, changes due to exogenous factors and relative 
compositions between portions of the intestine (7).   
 The inability of these researchers to provide complete conclusions due to the lack of 
intestinal data in humans alludes to the question “is fecal matter an adequate proxy for intestinal 
microbial composition?”. Many of the conclusions that microbiome researchers have drawn from 
studies of the gut microbiome are founded in the assumption that fecal matter is enough to 
describe the entirety of the intestinal tract, in terms of microbial composition (Table 1). Research 
using mouse models has the ability to extract intestinal matter and study said samples for 




intestines. No one has taken the task to provide a complete comparison of stool matter to 
intestinal matter microbial composition by looking at different portions of the intestine and stool 
to answer the question is fecal matter can be used to assess adequately the composition of the 
intestines. This experiment will allude to this dilemma by looking at the microbial composition 
of the intestinal tract in mice as well as stool and performing microbial community comparison 
analysis. It is of up most importance to answer this question, since conclusions about the 
intestinal tract have been made based off the assumption that fecal matter microbial composition 
is an adequate proxy for intestinal microbial composition. 









Feces Obesity ↓ Bifidobacterium sp. 2 
Feces Obesity ↑ Firmicutes:Bacteriodetes 10 





Immunomodulation Lactobacillus, Escherichia 
coli promote a Th2 or Treg 
differentiation.  
3,31 
Feces α-Synucelopathies Gavage of human fecal 
microbiome into germ free 
mice causes Parkinson’s 
pathophysiology in mice 
32 
Cecum Obesity Bacteroidetes was less 
abundant in obese mice 
33 
Cecum Obesity Gavage of lean mice into 
obese mice reduces fat 
percentage of obese mice  
14 
Cecum Diabetes Non-obese diabetic mice 
show a sex bias towards 
diabetes incident, which 
changes as microbial 
gavage is exchanged 







Microbial composition: Stool vs. Intestinal Tract 
 Microbial composition at the phylum level was found to be different in the stool than in 
all other sections of the intestine. The Bacteroidetes to Firmicutes ratio was specifically different 
in the stool from all intestinal sections, showing an increase in organisms belonging to the 
Bacteroidetes phylum and a decrease in organisms belonging to the Firmicutes phylum (Figure 
9). The colon showed the most resemblance to the composition of the stool, and the cecum 
(Figure 9). This was the case at all levels of taxonomy, although species level community 
comparisons were more complex and similar than those for higher taxonomic levels.   At the 
class level, differences between Bacteroides and Clostridia were observed between stool and all 
portions of the intestine tested. Other classes like Bacilli, Deltaproteobacteria, and 
Verrucomicrobiae were found to be more abundant in the ileum and colon than in the stool and 
cecum. Verrucomicrobiae was also found in small quantity in the cecum, but not as much as in 







Figure 9. Phylum level microbial composition of stool and intestinal tract (ileum, cecum and colon). Each 
designation on the X-axis is a mouse sample that corresponded to the specific class assigned. 
 
 





Significant differences among taxa were identified with an ANOVA using MicrobiomeAnalyst software. 
At the Phylum level, Firmicutes and Bacteroidetes were found to have significant differences 
between portions of the intestine and stool. Bacteroidetes abundance was found to be 
significantly different between stool and cecum samples, and stool and ileum samples (Table 2). 
Although not statistically significant, there were observable trends of differences between the 
ileum and the colon through less abundance of this phylum (Figure 11A). Firmicutes was also 
found to have a reversed profile from Bacteroides. Firmicutes was found to be significantly less 
abundant in the stool than in the cecum and to the ileum (Table 2). Observable trends also show 
that this phylum is not uniformly abundant across the intestinal tract. Although, no statistical 
significance was found, the colon also seems to have reduced abundance of Firmicutes compared 
to the cecum and the ileum, but it is still more abundant than in the stool. The ileum and cecum 































Figure 11. Relative abundance of statistically different 
phyla. (A) Bacteroidetes relative abundance by section of 
the intestinal tract ad stool. (B) Firmicutes relative 
abundance by section of the intestinal tract and stool. The 










































 Table 4. P-values for statistically significant comparisons at the phylum level. all 
P-values were calculated using a one-way ANOVA. 
Significant 
Comparison Phylum P-value 
Stool-Cecum Bacteroidetes 0.003 
Stool-Ileum Bacteroidetes >0.001 
Stool-Cecum Firmicutes 0.001 







At the class level there were two significant classes that had relevant abundance. The 
class Bacteroidea was found to be significantly more abundant in the stool than in the cecum and 
in the ileum. Although no significance was found, there is also an observable trend between the 
colon and stool as well, where this class is slightly more abundant in the stool than the colon. All 
intestinal portions were found to be very similar (Figure 12B). The class Bacilli was also found 
to be significantly different between the stool and portions of the intestine. Interestingly, the 
ileum was found to be significantly different for Bacilli communities than the colon, cecum and 
stool. The ileum was most different from stool, followed by the colon, and the cecum (Table 3). 
Differences within the Bacilli class can also be observed between the stool and the colon and 














































Figure 12. Relative abundance of statistically significant classes. 
(A) Relative abundance of the class Bacilli by section of the 
intestinal tract and stool. (B) Relative abundance of the class 
Bacteroidea by section of the intestinal tract and stool. Asterisks 









































Table 5. P-values for statistically significant comparisons at the Class level. 
 all P-values were calculated with a one-way ANOVA. 
Significant 






Stool-Cecum Bacteroidea 0.003 
Stool-Ileum Bacteroidea >0.001 
Ileum-Colon Bacilli 0.018 
Ileum-Cecum Bacilli 0.002 
Ileum-Stool Bacilli 0.001 
 
At the order level two taxa were found to be significant from all others. The order 
Bacteroidales was found to be significantly more abundant in the stool. Significance was found 
between stool and ileum samples and between stool and cecum samples (Table 3). Colon 
samples were not significantly different than those from the stool, but a trend can be observed, 
where Bacteroidales was found to be more abundance in stool than in the colon samples (Figure 
13A). The order Lactobacillales was found to be significantly less abundant in samples from the 
stool as compared to the ileum, as well. Lactobacillales was also found to be significantly more 
abundant in the ileum than in the cecum and colon (Table 4). Trends in differences between the 
stool and the colon samples were also observed, but none were significantly different. The range 
of abundances for Lactobacillales samples was found to be very broad between the samples, 

















































Figure 13. Relative abundance of statistically significant 
orders. (A) Relative abundance for the order Bacteroidiales by 
section of the intestinal tract and stool. (B) Relative 
abundance of the order Lactobacillales by section of intestinal 










































Table 6. P-values for statistically significant comparisons at the Order level. 
 all P-values were calculated with a one-way ANOVA. 
Significant 
Comparison Order P-value 
Stool-Ileum Bacteroidales <0.001 






Stool-Ileum Lactobacillales 0.001 
Ileum-Cecum Lactobacillales 0.003 
Ileum-Colon Lactobacillales 0.019 
 
At the family level two features were found to be significantly different from the rest. 
The family Rikenellaceae was found to be significantly more abundant in stool samples than in 
all other intestinal portions. The largest difference was observed between stool and ileum 
samples, followed by stool and cecum samples, and stool and colon samples (Table 5). There 
were also two observable trends that showed cecum samples being different than the ileum and a 
large range of differences among samples taken from the colon (Figure 14). The family 
Porphyromonadaceae was found to be significantly different between the stool and two portions 
of the intestine. This family was found to be significantly more abundant in samples from the 
stool than from the cecum, or from the ileum (Table 5). Observable trends show that 
Porphyromonadaceae was also more abundant in the stool than in the colon, although no 
































Figure 14. Relative abundance of statistically significant 
families. (A) Porphyromonadaceae relative abundance across 
the intestinal tract a stool. (B)  Rikenellaceae relative 
abundance across the intestinal tract and stool. Asterisks 
represent outliers. Asterisks represent outliers.  
 

































Table 7. P-values for statistically significant comparisons at the Family level.  





Stool-Cecum Porphyromonadaceae 0.006 
Stool-Ileum Porphyromonadaceae 0.003 
Stool-Ileum Rikenellaceae >0.001 
Stool-Cecum Rikenellaceae 0.001 







Three genera were found to differ significantly in types and relevant abundance across 
the intestinal tract. The genus Alistipes was found to be more abundant in the stool samples than 
in all other intestinal portions tested. The largest difference was found between samples from the 
stool and the ileum, followed by the cecum and the stool, and the stool and the cecum (Table 6). 
Interestingly, samples from the cecum and the ileum seem to be very different, although there 
was no statistical significance found between these two sample types. Samples from the colon 
showed a high range of data points (Figure 15). The genus Odoribacter was also found to differ 
significantly between samples from the intestine and stool. Bacteria belonging to the genus 
Odoribacter were found to be significantly more abundant in stool samples than in all three 
portions of the intestine tested. The largest difference was found between samples from the stool 
and the ileum, followed by the colon, and the cecum (Table 6). All portions of the intestine seem 
to be very similar although cecum samples showed some difference when compared to the ileum, 
no statistical significance was found (Figure 15). Lastly, the genus Porphyromonas was found to 
have significantly different abundances between samples from the stool and from portions of the 
intestine. Stool samples were found to have higher abundance of Porphyromonas than samples 
from the cecum and the ileum (Table 6). There is also a trend that can be observed between colon 
and ileum samples showing that the colon has higher abundance of Porphyromonas species than 
the ileum, although no statistical significance was found. There was a high variability data points 
among the colon samples differences between samples (Figure 15). Species level univariate 
analysis showed many significant features, but they were omitted due to most of them having 












































Figure 15. Relative abundance for statistically significant genera. (A) Porphyromonas relative abundance 
across the intestinal tract and stool. (B) Odoribacter relative abundance across the intestinal tract and stool. (C) 


































Table 8. P-values for statistically significant comparisons at the Genus level.  
all P-values were calculated with a one-way ANOVA in MiniTab. 
Significant 
Comparison Genus P-value 
Stool-Ileum Alistipes <0.001 
Stool-Cecum Alistipes <0.001 
Stool-Colon Alistipes <0.001 
Stool-Ileum Odoribacter <0.001 
Stool-Cecum Odoribacter <0.001 
Stool-Colon Odoribacter 0.003 
Stool-Ileum Porphyromonas 0.008 








At the species level there were two species that were relevantly abundant and 
significantly different between samples from the intestine and the stool. The species Bacteroides 
acidifaciens was found to be slightly more abundant in samples from the stool than from the 
ileum. Although only this comparison was found to be significant, observable trends show more 
abundance in stool than the cecum (Table 7; Figure 16). The organism was similarly abundant 
between portions of the intestine. Also, a high amount of variation was found among stool 
samples (Figure 16). The species Dorea massiliensis was more abundant in samples from the 
stool than in all portions of the intestine. This organism was more abundant in samples from the 
stool than from the ileum the most, followed by the colon and cecum. All portions of the 
intestine where similar (Table 7). The range of the colon samples was very high suggesting large 
differences in D. massiliensis abundance from individual to individual. Although, only the stool 
was significantly different from the intestine, observable trends suggest that there might be a 
difference between colon and ileum, but due to the large variability within colon samples, 














































Figure 16. Relative abundance for statistically 
significant species. (A) Bacteroides acidifaciens 
percentage abundance across the intestinal tract and 
stool. (B) Dorea massiliensis percentage abundance 
































Table 7. P-values for statistically significant comparisons at the Species level. 
 all P-values were calculated with a one-way ANOVA. 
Significant 
Comparison Species P-value 
Stool-Cecum Dorea massiliensis 0.001 
Stool-Ileum Dorea massiliensis <0.001 
















Alpha-diversity was assessed by Shannon’s Diversity Index and β-Diversity was assessed by 
Bay-Curtis dissimilarity test. At the genus level of taxonomy there were no significant difference 
between the intestine and the stool when looking at α-diversity (Figure 17). The Bay-Curtis 
analysis for β-diversity showed significance within the comparisons between the stool and 
intestine. Stool was found to be more diverse than the ileum (P-value: 0.003). Observable trends 
show individual clustering between the parts of the intestine and stool, suggesting that there is a 
difference between all portions of the intestine and stool (Figure 18). 
 
Figure 17. Shannon's diversity index of each intestinal portion and stool. No significance was observed 





Figure 18. β-diversity analysis. PCOA showing Bay-Curtis Dissimilarity test data. Statistical significance 




Bacterial composition and diversity were compared between fecal samples and intestinal 
samples in mice. Mouse bacterial composition is similar to human bacterial composition, 
although abundance seem to be different. For example, mice and humans share some genera 
including Alistipes, Odoribacter and Turicobacter but some are in lower abundance in mice than 
in humans (6). Even so, mice are a good model for intestinal microbial community comparison 
because the intestinal tract is similar in composition, although the researchers admit that the 
strength of these findings is lowered due to only observing fecal matter. (7;8).  
The intestinal microbial composition of humans and mice a like, has been explored 
thoroughly, while fecal matter has been used extensively to draw conclusions about the many 
phenomena that the gut microbiome is connected to, no one has taken on the task of comparing 




composition of the intestinal tract and stool of mice as well as the diversity of the microbiome 
across the mouse intestinal tract we can shed some light into the adequacy of the assumption that 
fecal matter bacterial composition is a proper proxy for intestinal microbial composition.  
At the phylum level of taxonomy, bacterial composition was found to be different between stool 
and all portions of the intestine. The phylum Firmicutes was found to be significantly more 
abundant in stool and the ileum (Figure 15). This profile, then, is very similar to that of the 
cecum and colon where the Firmicutes to Bacteroidetes ratio is highly dominated by 
Bacteroidetes. This finding suggests that as the intestinal tract proceeds from proximal to distal 
end, there is a change in microbial composition observed at the phylum level. Previous studies in 
the composition of the intestinal tract have found similar observations, by concluding that 
diversity and complexity of the intestinal tract increases from proximal to distal end (4). This 
does not only occur at the phylum level, but at all lower levels of taxonomy. The phyla 
Firmicutes and Bacteroidetes have are highly studied taxa, and have been correlated to obesity. 
The Firmicutes to Bacteroidetes ratio has been previously used to determine an obese 
composition. In a study aimed to assess the energy harvest capacity of an obese microbiome, 
researchers used fecal samples to assess the composition of the intestinal tract and how it is 
correlated to obesity. They found higher Firmicutes than Bacteroidetes is a characteristic of an 
obese phenotype (11). Our findings suggest that Bacteroidetes is often lower than Firmicutes in 
stool (Figure 11B). At the class level of taxonomy, the microbiome for the ileum was very 
different, not only from the stool, but also from all portions of the intestine sampled. Classes 
such as Clostridia and Bacteroidea are very similar across the intestinal tract, but are found to be 
in different proportions in the stool; the class Clostridia is found in low numbers in stool samples 




intestines. Other classes are also more abundant in certain portions of the intestinal tract than in 
the stool, for example the class Bacilli was found to be highly abundant in the ileum, but not in 
the stool, suggesting that along the intestinal tract, the organisms belonging to this class are not 
reaching stool. Some of these findings are in agreement with previous research. Sheghuan and 
colleagues (9) found the class Bacilli to be highly abundant in the ileum, but less abundant in 
other portions of the intestinal tract. This class is a target of study for the effects of diet in the gut 
microbiome. A study assessing the effects of diets on the humanized mice microbiome found that 
the class bacilli is highly abundant in Western diets, but less abundant in other diets, suggesting 
that western countries have different microbiomes due to the diet that is often consumed (12). 
This experiment only used fecal matter to draw conclusions about the intestinal tract 
composition. Our findings suggest that the mouse microbiome has low bacilli in stool. The class 
Bacteroidea, was found to have a similar abundance across the intestinal tract, although they 
found it to be high in the Ileum, which is in opposition to our findings (9). This difference might 
be due to strain and diet differences between the studies.  
  The genera Odoribacter, Porphyromonas and Alistipes were found to be more abundant 
in the stool than in all portions of the intestine. Organisms belonging to the Alistipes are very 
relevant, and have opened an avenue of research concerning the gut-brain axis (27). Previous 
research, which used only fecal matter for samples, found that this genus is decreased in mice 
that experience severe stress and when gavaged into germ-free mice yielded a stress phenotype 
(27). Interestingly it was found high in stool in our study, which might suggest that the depletion 
of this organism during stress events might occur in the colon, which was found to be similar 
form stool across all taxa. The genus Odoribacter is a known commensal organism in the human 




(14). It was not specified which portion of the intestine this organism was most prevalent in or if 
it is transient or if it colonizes the intestine since they only used fecal matter at one point in time 
(14). Our study suggests that it is not highly abundant in the intestinal tract, but highly abundant 
in stool, which might suggest why the previously mentioned project observed it to be in such 
high abundance. Another relevant genus that was found to differ in abundance between stool and 
the intestinal tract is the Porphyromona genus, although most of the research around this genus 
has been focused in a specific organism, Porphyromonas gingivalis, which has been foud to have 
an effect in Alzheimer patients. Periodontal pathogen antibodies have been found in significantly 
high amounts in Alzheimer patients. The researchers suggest that organisms like Porphyromonas 
gingivalis are connect pathophysiology of the disease (28).  
 At the species level, organisms known to be important to health, in terms of immune 
responses, were found to be different. The organism Bacteroides acidifaciens was found to be 
significantly more prevalent in stool. This organism is known for reducing inflammation, 
improving glucose sensitivity and reducing obesity in mice. These conclusions were drawn from 
mouse ceca, but also only from human feces suggesting that the results might be skewed due to 
inaccuracy (10). Dorea massiliensis was found to be more abundant in stool than in any other 
portion of the intestine. This organism has not been highly studied, since it was a candidate 
organism, or an organism that is in the process of being assigned to that certain taxonomic 
assignation, until recently (29). Researchers that assigned this taxonomic name found this 
organism in a single stool sample from an Anorexia nervosa patient (29).  
 When looking at diversity, specifically the Shannon’s index, there was no significance 
found. These findings contradict previous research that puts the diversity in the ileum being 




other hand, showed significance between the stool and ileum. The stool was more diverse and it 
clustered together apart from the ileum, which clustered together as well (Figure 18). Sheguan 
and colleagues found similar results, where local diversity was found to be significantly different 
between the intestinal tract (9). Our findings suggest that just stool is differently diverse, but due 
to different methodology and diet, conclusions might be different.  
 There is convincing evidence showing that the microbial composition of the stool and the 
intestinal tract is different. These findings suggest that fecal matter is not an adequate proxy for 
intestinal microbial composition. Within the intestine there is also variability in the microbiome. 
Therefore, individual portions of the intestine should be looked at separately when making 
conclusions about the microbial composition and abundance of the gut. Similar to our findings, 
Shenghuan and colleagues also found that each portion of the intestines has its own community, 
showing multiple differences between the jejunum, ileum, cecum and colon (9). Our findings 
suggest that microbial composition along the intestinal tract changes, as reported by others (9), 
and now we add that fecal matter also has different microbial composition from regions of the 
intestine. Further research needs to be performed on this matter. Research alluding to viability of 
microbial cells, would answer this question with a more encompassing conclusion. In this 
experiment we lacked the ability to differentiate between viable and non-viable cells. Most 
microbes in our gut and mouse gut are obligate anaerobes, therefore it is important to look at 
viability in stool, specifically. These organisms would have died as soon as contact with oxygen 
was had and they would not be considered part of the fecal microbiome at said point in time. 
Although, viability is an issue that needs to be researched more, our findings still suggest that 
there are differences between the microbial composition of the intestinal tract and stool. Stool 




microbiome, but should not be considered an adequate proxy for intestinal bacterial composition 
and diversity.  
Methods 
Tissue and stool collection 
Eight approximately six-week-old wild-type C57BL/6 male mice were used in this study. 
All mice were housed and maintained under Protocol #A101604, which was approved by the 
Central Washington University Institutional Animal Care and Use Committee.  All mice had 
access to food ad libitum and were fed Mazuri Rodent Breeder 6F diet. This diet is composed of 
16% crude protein, 6% crude fat, 7% crude fiber, 12% moisture and ~8% mixture of various 
minerals.  Stool samples were collected 30 seconds before euthanasia by placing the mice on a 
disinfected tray and allowing the mice to produce stool pellets, which were collected aseptically 
and stored at -80°C until DNA extraction. Following stool collection, mice were euthanized by 
rendering CO2 followed by cervical dislocation. Following euthanasia and using aseptic 
technique, the intestinal tract was removed from each mouse. The intestinal tract was aseptically 
divided into ileum, cecum and colon, then stored at -80°C until DNA extraction.   
 
DNA extraction and 16S rDNA amplicon sequencing 
Intestinal samples were sub-sectioned into three 25mg-35mg tissue sections. DNA from 
all intestinal samples was extracted using the DNeasy kit (Qiagen, Inc., Germantown, MD) for 
tissue and blood. DNA was then quantified using absorbance at 260 nm on a Beckman DU 640B 
UV spectrometer, and quality was assessed using the 260/280 nm ratio. The extracted DNA were 




extraction kit (Qiagen, Inc., Germantown, MD). DNA for these samples was also quantified and 
checked for quality via UV absorbance using the same parameters, and stored at -80ºC. All DNA 
samples were sent to Mr. DNA Laboratory (Shallowater, TX) for 16S rDNA amplicon 
sequencing and taxonomic assignment. The 16S rRNA V4 variable region PCR primers 515/806 
were selected for use in a one-step 30 cycle PCR. The HotStarTaq Plus Master Mix Kit (Qiagen, 
USA). The following conditions were used for PCR: 94°C (3 minutes), followed by 30 cycles of 
94°C (30 seconds), 53°C (40 seconds) and 72°C (1 minute), after which a final elongation step at 
72°C (5 minutes). Sequencing was performed on an Ion Torrent PGM using manufacturer’s 
protocol. Sequence data was processed with proprietary analysis pipeline (MR DNA, 
Shallowater, TX, USA).  
Microbial Community Comparison and Statistical Analysis  
Microbial community comparison was assessed using the MicrobiomeAnalyst Web-based 
software. The Marker Data Profiling (MDP) module was used, which takes 16S rDNA data and 
yields relative abundance, univariate analysis, α−diversity, β-diversity and significance through 
statistical tests like Analysis of Variance and Mann-Whitney test. The data set was not 
normalized, but was subjected to total sum scaling. This allows for more robust statistical 
analysis. All OTU counts less than 4 and all sequences data representing less than 10% of the 
whole data set were removed as a filtering method to minimize possible sequencing errors and 
DNA contaminants. Performing this data filtering removed a total of 408 features from the data 
set.  
Alpha diversity was assessed by Shannon’s Diversity Index, and significance was 
assessed using an ANOVA with a Tukey post-hoc test. Beta Diversity was assessed by Bay-




post hoc Tukey test. All statistical tests were performed by MirobiomeAnalyst or in MiniTab 
(Ryan et al., University of Pennsylvania, 1972). All statistical tests were performed with a 0.05 
P-value parameter in MiniTab.    
Univariate analysis was performed using MicrobiomeAnalyst at all levels of taxonomy. 
Individual significant features that had relevant abundance within the data set were separated and 
assessed for significance individually. Significance was assessed by a one-way ANOVA followed 
by a post hoc Tukey test to assess the source of the difference or similarity. All statistical tests 
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